Andrew Guggenhime - 08 Jul 2022 Form 4 Insider Report for Vaxcyte, Inc. (PCVX)

Role
President and CFO
Signature
Andrew Guggenhime, by /s/ Ron Metzger, Attorney-in-Fact
Issuer symbol
PCVX
Transactions as of
08 Jul 2022
Net transactions value
-$57,815
Form type
4
Filing time
12 Jul 2022, 17:12:24 UTC
Previous filing
06 Sep 2022
Next filing
20 Jul 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PCVX Common Stock Options Exercise $16,585 +3,100 +7.3% $5.35 45,287 08 Jul 2022 Direct
transaction PCVX Common Stock Sale $74,400 -3,100 -6.8% $24.00 42,187 08 Jul 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PCVX Stock Option (right to buy) Options Exercise $0 -3,100 -0.62% $0.000000 499,818 08 Jul 2022 Common Stock 3,100 $5.35 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan.
F2 1/4 of the shares subject to the option vested on May 1, 2021, and 1/48 of the shares vest monthly thereafter.